← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2025-05-15 16:30:00 | Msa Safety To Participate In Upcoming Investor Conferences Pittsburgh , may 15, 2025 /prnewswire/ -- msa safety incorporated (nyse: msa), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, announced its participation in the following upcoming investor conferences. conference 25 th annual b. |
| 2025-05-14 07:50:00 | Glass House Brands And Leef Announce Msa For The Leaf El Paseo Dispensary And Off-take Agreement Vancouver, british columbia, may 14, 2025 (globe newswire) -- leef brands inc. (cse: leef) (otcqb: leeef) (“leef” or the “company”), one of california’s premier vertical extraction companies, today announced a management services agreement (“msa”) with glass house brands, inc. (cboe ca: glas.a.u) (cboe ca: glas.wt.u) (otcqx: glasf) (otcqx: ghbwf), a leading vertically integrated cannabis operator in the united states. under the msa, glass house will manage operations of leef’s palm desert, california, dispensary, “the leaf el paseo,” on behalf of leef. |
| 2025-05-14 07:45:00 | Glass House Brands And Leef Announce Msa For The Leaf El Paseo Dispensary And Off-take Agreement Long beach, calif. and toronto, may 14, 2025 (globe newswire) -- glass house brands inc. (’glass house’ or the ’company’) (cboe ca: glas.a.u) (cboe ca: glas.wt.u) (otcqx: glasf) (otcqx:ghbwf) – one of the fastest-growing, vertically integrated cannabis companies in the united states, and leef brands, inc. (cse: leef) (otcqb: leeef), one of california’s premier vertical extraction companies, today announced a management services agreement (“msa”). under the msa, glass house will manage operation of leef’s palm desert, ca dispensary “the leaf el paseo” on behalf of leef. |
| 2025-05-09 12:00:00 | Theravance Biopharma Announces Ampreloxetine Presentations At The International Msa Congress Dublin , may 9, 2025 /prnewswire/ -- theravance biopharma, inc. (’theravance biopharma’ or the ’company’) (nasdaq: tbph) today announced presentation of analyses of its previous phase 3 program evaluating ampreloxetine, an investigational medicine for the treatment of symptomatic neurogenic orthostatic hypotension (noh) at the international msa congress, taking place may 9-11 in boston, massachusetts. a subgroup analysis selected as a platform presentation focused on patients with multiple system atrophy (msa) in the redwood 0170 study (nct03829657), an international phase 3, placebo-controlled, double-blind, randomized withdrawal trial, designed to demonstrate clinical worsening in those assigned to placebo. |
| 2025-05-07 16:30:00 | Msa Safety Acquires M&c Techgroup, A Leading Manufacturer Of Gas Analysis Solutions And Technologies Acquisition expands msa’s detection solutions and adds new capabilities in the gas analysis and process safety markets with annual revenue of approximately $55 million, m&c techgroup is highly complementary to msa’s technology, customer base and distribution network transaction expected to be accretive to msa’s adjusted earnings in 2025 pittsburgh , may 7, 2025 /prnewswire/ --global safety equipment and solutions provider msa safety incorporated (nyse: msa) today announced it has acquired m&c techgroup in a transaction valued at approximately $200 million. based in ratingen, germany, m&c techgroup provides a comprehensive range of gas analysis systems that detect, measure and monitor gases in critical environments. |
| 2025-05-07 08:16:00 |
|
| 2025-05-02 08:30:00 |
|
| 2025-04-30 07:35:00 |
|
| 2025-04-29 16:30:00 |
|
| 2025-04-28 16:30:00 |
|
| 2025-04-28 07:35:00 |
|
| 2025-04-28 06:00:00 |
|
| 2025-04-15 16:30:00 |
|
| 2025-04-09 08:15:00 |
|
| 2025-03-17 13:49:00 |
|
📰 Browse additional press releases for MSA Safety!
Sign up for free or log in📥 Get our free eBook now: "The Checklist Value Investor — A Smarter Way to Pick Stocks"